ResultsIQ › Latest results › Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited Q2 FY27 results deck summary
NSE: JSLL · BSE: 544476
Results deck of 15 Nov 2026, summarised by AI from the filing.
Q2FY27 revenue rose 24% YoY to ₹23,513 lakh but EBITDA margin fell to 31% as brand and manpower spend rose.
Key takeaways
- Q2 revenue Q2FY27 revenue from operations ₹23,513 lakh, up 24% YoY from ₹18,985 lakh, with gross margin at 88%.
- Bed target Management targets 5,000 beds in 2–5 years and 10,000 beds in 5–10 years, from 3,031 total beds now.
- Margin drop Q2FY27 EBITDA margin fell to 31% from 41% in Q1FY27 as advertisement, manpower and ECL costs rose.
- Volume growth Growth was volume-led across both verticals, with H1FY27 IPD volumes up 23% YoY to 22,480.
- Margin risk Higher advertisement and promotion spend of ₹13.4 crore and ECL provision of ₹2.5 crore weighed on Q2FY27 profitability.
Jeena Sikho Lifecare Limited Q2 FY27 results
As filed: Revenue ₹235 cr (+24% year on year), EBITDA ₹72.0 cr (−22% year on year), PAT ₹36.6 cr (−38% year on year), EBITDA margin 30.6% (−1,000 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹224 cr (+29% year on year), EBITDA ₹92.1 cr (+15% year on year), PAT ₹65.9 cr (+29% year on year), EBITDA margin 41.0% (−495 bps). Score 62 of 100, In line with trend. EBITDA margin fell 495 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −13.7% in 28 days (Nifty 500: −1.9%).
- Q4 FY26: Revenue ₹216 cr (−15% year on year), EBITDA ₹78.0 cr (+18% year on year), PAT ₹45.4 cr (+3% year on year), EBITDA margin 36.2% (+1,000 bps). Score 41 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 32% from last quarter. Share price after the results: −4.6% in 30 days (Nifty 500: +1.5%).
- Q3 FY26: Revenue ₹222 cr (+74% year on year), EBITDA ₹101 cr (+205% year on year), PAT ₹66.7 cr (+203% year on year), EBITDA margin 45.5% (+1,000 bps). Score 100 of 100, Above trend. EBITDA margin rose 1000 bps year on year. Year-ago figures are half of the company's half-year result (it reported half-yearly then). Not enough history for a trend yet: scored on growth alone. Share price after the results: −14.4% in 30 days (Nifty 500: −5.9%).
- Q2 FY26: Revenue ₹190 cr (−11% year on year), EBITDA ₹92.1 cr (+56% year on year), PAT ₹58.8 cr (+25% year on year), EBITDA margin 48.5% (+1,000 bps). Score 60 of 100, In line with trend. EBITDA margin rose 1000 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −12.8% in 29 days (Nifty 500: +1.4%).
- Q1 FY26: Revenue ₹174 cr (+63% year on year), EBITDA ₹80.0 cr (+171% year on year), PAT ₹51.0 cr (+117% year on year), EBITDA margin 46.0% (+1,000 bps). Score 100 of 100, Above trend. EBITDA margin rose 1000 bps year on year. Year-ago figures are half of the company's half-year result (it reported half-yearly then). Not enough history for a trend yet: scored on growth alone. Share price after the results: +40.7% in 29 days (Nifty 500: +2.2%).
- H2 FY25: Revenue ₹255 cr, EBITDA ₹66.0 cr, PAT ₹44.0 cr, EBITDA margin 25.9%. Not scored. No result for the same half-year last year.
- Q2 FY25: Revenue ₹214 cr (+173% year on year), EBITDA ₹59.0 cr (+162% year on year), PAT ₹47.0 cr (+194% year on year), EBITDA margin 27.6% (−109 bps). Score 89 of 100, Above trend. EBITDA margin fell 109 bps year on year. Year-ago figures are half of the company's half-year result (it reported half-yearly then). Not enough history for a trend yet: scored on growth alone.
Past price moves after results do not indicate future moves. Not a recommendation.
Jeena Sikho Lifecare Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (15 Nov 2026)
- Q1 FY27: Earnings call (10 Aug 2026), Results deck (9 Aug 2026)
- Q4 FY26: Earnings call (2 Jun 2026), Results deck (31 May 2026), Results deck (1 Jun 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (8 Feb 2026)
- Q2 FY26: Earnings call (7 Nov 2025), Results deck (6 Nov 2025)
- Q1 FY26: Earnings call (18 Aug 2025), Results deck (15 Aug 2025), Results deck (16 Aug 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.